Kenneth Harrison joined Novo Holdings Venture Investments (US) Inc. in San Francisco in 2015 and is a Senior Partner. Before Novo Holdings he was a Senior Market Planning Manager at Genentech, helping guide strategic decision making for the ophthalmology and HER2 franchises. Earlier he worked as a management consultant at L.E.K. Consulting and as Entrepreneurship Program Manager at QB3/Mission Bay Capital, where he helped create programmes to launch and support life sciences companies in the Bay Area. He holds a PhD in pharmacology from Yale University and a BS in molecular biology from Texas Tech University, and was an A.P. Giannini Foundation Fellow at the J. David Gladstone Institutes.
Education
PhD in Pharmacology, Yale University
BS in Molecular Biology, Texas Tech University
A.P. Giannini Foundation Fellow, J. David Gladstone Institutes
Previous Experience
QB3/Mission Bay Capital - Entrepreneurship Program Manager
L.E.K. Consulting - management consultant
Genentech - Senior Market Planning Manager, Ophthalmology and HER2 franchises